Health insurance in Portugal gets sold on two things: the monthly premium and the size of the provider network. Both are easy to compare, and neither tells you what happens when you actually get ill. That answer lives in the exclusions and the waiting periods, which is the part of the documentation nobody reads until it’s relevant.
There’s now a useful yardstick for judging a policy, and it comes from the regulator rather than an insurer.
The Regulator’s Own Benchmark
In June 2025 the ASF, Portugal’s insurance supervisor, issued Circular 6/2025 setting out “condições padrão” for health insurance: a fixed, comparable set of covers and capitals intended to protect people against the costs that do real financial damage. It specifies four covers, with hospitalization capped at €30,000, outpatient care at €1,000, preventive medicine included, and serious illness at €300,000.
Read what it leaves out. The standard excludes dentistry, prosthetics, orthotics and medication. The regulator’s own model of adequate health cover does not pay for drugs.
Adoption is voluntary. Insurers can offer broader or more personalized products, and only compliant ones may claim conformity with the circular. So it’s a benchmark to measure a quote against, not a floor you can assume.
Oncology Is the Clearest Case
Medication being outside the standard matters most where the drugs are the expensive part, which means cancer.
Read an actual policy rather than a brochure and the structure shows. In Allianz’s general and special conditions for Allianz Saúde (the version marked 12/2020, which is the one published at the time of writing, so check the current edition against your own policy), oncology is a separate cover you subscribe to, referred to throughout as “a Cobertura de Oncologia, se subscrita”. Other covers then carve out what falls inside it. The medication cover excludes “despesas com medicamentos abrangidas pela Cobertura de Oncologia”. The dental cover excludes oncology-related stomatology. Several others exclude “quaisquer despesas abrangidas pela cobertura de Oncologia”.
If you didn’t subscribe that cover, those costs don’t fall back on the general policy. They fall through it. A policy can look complete and contain a hole shaped exactly like the diagnosis you were worried about.
What sits underneath is substantial. In SNS hospitals the medication needed to treat oncological disease is provided free to the patient, including on an outpatient basis. INFARMED lists this under its regimes excecionais de comparticipação, which apply 100% funding to medication dispensed by hospital pharmacies to patients who aren’t admitted. Oncology patients are exempt from taxas moderadoras on related consultations, and since 1 June 2022 taxas moderadoras were removed across the SNS, surviving only for emergency care attended without a referral.
So if the state pays for the drugs, what is private oncology cover for? Timing, and here the timing is poor. On the Patients W.A.I.T. Indicator 2025 figures, Portugal’s average wait between European approval and effective reimbursement is 839 days across all medicines against an EU average of 597. For cancer medicines specifically, Portugal takes 926 days against an EU average of 655.
Breadth is the flip side, and Portugal does well on it. It made available 34 of the 56 approved cancer medicines, 61%, above the EU average of 51%. Across all medicines the EMA approved between 2021 and 2024, Portugal funded 89 of 168, or 53%, against an EU average of 45%. The system funds a wide range of drugs and takes two and a half years to get to the cancer ones.
For a patient that gap has a shape. The drug exists, your oncologist knows about it, and the SNS won’t be paying for it for another couple of years.
Portugal runs a bridge, the Programa de Acesso Precoce, where a manufacturer supplies an innovative medicine free of charge before the funding decision. The bar is high: no funded therapeutic alternative, plus a serious clinical situation or immediate risk to life. A PAP opens when nothing funded works for you, which is stricter than a newer drug simply performing better than the funded one. The space between those two bars is what a private oncology rider actually buys.
Pre-existing Conditions, and What the Law Allows
Under article 216 of Decreto-Lei 72/2008, the regime governing insurance contracts, pre-existing conditions known to the insured at the date of the contract are treated as covered, and may be excluded only by agreement to the contrary, either generically or specifically. Where they are covered, the contract may impose a waiting period of no more than one year.
Policies routinely take the exclusion option, and the wording is blunter than buyers expect. The Allianz conditions exclude “despesas médicas efetuadas com uma doença pré-existente, declarada ou não”, along with conditions or symptoms clinically shown to be related to it.
Declaring honestly doesn’t buy you cover there. It buys an accurate picture of what you haven’t got, which is worth having. If you arrive with anything on your record, that clause deserves reading before the premium does.
The Waiting Periods Are Longer Than the Headline
Brokers tend to say 90 days. The ASF standard sets 60 days for outpatient care and preventive medicine, 180 for hospitalization and for serious illness, and 310 for childbirth.
Individual products go further. The 2020 Allianz conditions put a 365-day period on childbirth and caesarean, and on hernia treatment, kidney and gallbladder stones, proctological surgery, gastro-oesophageal procedures, benign gynaecological and endocrine surgery, ENT surgery for benign pathology, and joint procedures by arthroscopy or arthrotomy.
That’s a year before one policy pays for a good deal of ordinary surgery. If you’re buying cover mainly to skip an SNS waiting list, check which tier your likely procedure sits in, because the first year may leave you where you started.
The Gaps People Hit More Often Than Cancer
Oncology is the most expensive gap. It isn’t the most frequent one.
Network and reimbursement is the one that generates the most complaints. Inside the insurer’s rede convencionada you pay a copayment. Outside it you pay in full and claim back against the insurer’s own table, which may sit well below what the clinic charged. A policy sold on the size of its network says nothing about what happens when the specialist you want isn’t in it.
Annual capitals are set per cover rather than per policy, so a single admission can exhaust a hospitalization ceiling while the outpatient budget sits untouched. Copayments and franquias stack on top, and none of it appears in a premium comparison.
Then there’s the cover that stays technically in force while becoming unaffordable. Premiums rise with age, and a policy you can’t renew at 70 because of the price is as much a gap as one that excludes you outright.
Worth asking about specifically, because they vary a lot and I wouldn’t assume either way: mental health and psychology sessions, chronic condition management, and dental beyond a token plafond.
Age Limits
Some insurers cap the age at which you can take out a policy, and some products cap the age at which you can stay in one. Being dropped at 70 after two decades of premiums is the outcome that makes the whole purchase questionable, and the ASF standard conditions don’t address age, so there’s nothing to fall back on. Ask directly what happens at 65, 70 and 75, and get it in writing.
What to Ask Before You Sign
“Does it cover cancer” is the wrong question, because the answer is a qualified yes that comes apart at the pharmacy. Better ones:
- Is oncology a separate subscribed cover, and does it pay for drugs holding EU marketing authorization that don’t yet have SNS funding?
- What’s the annual ceiling on that cover, and does it pay inside Portugal or only abroad with prior agreement?
- What exactly is excluded as pre-existing, given what’s already on my record?
- Which procedures sit in the longest waiting tier rather than the 60-day one?
- What does reimbursement outside the network actually pay, as a percentage of a typical private bill?
- Does this product claim conformity with ASF Circular 6/2025, and if not, where does it fall short of it?
- What happens to my premium and my cover at 70?
Brokers here largely distribute the same insurers’ products, so comparing headline premiums between them tells you less than you’d hope. Ask two of them to quote the same family with the oncology cover included and priced as its own line, and the real difference becomes visible.
Register With the SNS Regardless
I’ve been based in Cascais since 2026, and this is the item I’d move to the front of the list rather than the back. Every gap above is cushioned by the public system, and none of that applies until you’re registered.
The número de utente is free and issued at your local UCSP. Having one isn’t the same as being covered: the record needs an identification document, a Portuguese NIF, a complete Portuguese address and valid proof of residence, and for an EU citizen that last item is normally the Certificado de Registo de Cidadão da União Europeia from your câmara. Ask to be assigned a médico de família in the same visit.
Serious disease here is sometimes described as an SNS monopoly, with cancer supposedly impossible to treat privately. That isn’t the case. The Champalimaud Clinical Centre in Belém is a private foundation centre providing specialized oncology care since 2011, with an international patients’ office, and CUF, Lusíadas and Hospital da Luz all run oncology departments. What pushes people toward the public system for the expensive part is funding rather than law.
It slots in alongside the rest of the setting-up-in-Portugal list. If you’re weighing Portugal against Spain, I’ve written separately about the Spanish side, and the residency and tax mechanics sit in the piece on Portugal’s low-tax regime.
The Short Version
Portuguese private health insurance is worth having for speed on diagnostics, consultations and elective surgery once the waiting periods clear. It isn’t a substitute for the SNS, and the regulator’s own standard product doesn’t even cover medication. Read the exclusions and the carência table before the premium, subscribe the oncology cover by name if you want it, and get your número de utente either way.
Figures here are from the ASF Circular 6/2025 standard conditions, the Patients W.A.I.T. Indicator 2025, and one insurer’s published conditions dated December 2020. Clauses differ between insurers and change between policy versions, so treat this as a guide to what to look for rather than a description of your own contract, and read your own conditions document.
Related
Leave a Reply